Goldman Sachs is out with an analyst note this morning, where it suggests that investors position for downside in Intuitive Surgical, Inc. ISRG by buying 1x2 put spreads.
The report noted that Goldman Sachs Medical Devices analyst, David Roman, Rates ISRG Sell and sees 22% downside to his $220 12-month price target. He also expects the company to disappoint with its full year 2011 revenues and EPS, where he is 4% below consensus on both.
The GS analysts suggest playing this thesis by buying the January $280/250 1x2 put spread for $7.30.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorShort IdeasOptionsTrading IdeasGoldman SachsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in